Skip to main content
Journal cover image

Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.

Publication ,  Journal Article
Harskamp, RE; Alexander, JH; Lopes, RD
Published in: Eur J Intern Med
July 2019

Duke Scholars

Published In

Eur J Intern Med

DOI

EISSN

1879-0828

Publication Date

July 2019

Volume

65

Start / End Page

4 / 5

Location

Netherlands

Related Subject Headings

  • Stroke
  • Randomized Controlled Trials as Topic
  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Humans
  • Hematologic Agents
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Drug Therapy, Combination
  • Coronary Artery Disease
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Harskamp, R. E., Alexander, J. H., & Lopes, R. D. (2019). Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS. Eur J Intern Med, 65, 4–5. https://doi.org/10.1016/j.ejim.2019.05.018
Harskamp, Ralf E., John H. Alexander, and Renato D. Lopes. “Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.Eur J Intern Med 65 (July 2019): 4–5. https://doi.org/10.1016/j.ejim.2019.05.018.
Harskamp, Ralf E., et al. “Navigating the treacherous waters of antithrombotic therapies in patients with atrial fibrillation and coronary artery disease: Lessons from AUGUSTUS.Eur J Intern Med, vol. 65, July 2019, pp. 4–5. Pubmed, doi:10.1016/j.ejim.2019.05.018.
Journal cover image

Published In

Eur J Intern Med

DOI

EISSN

1879-0828

Publication Date

July 2019

Volume

65

Start / End Page

4 / 5

Location

Netherlands

Related Subject Headings

  • Stroke
  • Randomized Controlled Trials as Topic
  • Platelet Aggregation Inhibitors
  • Percutaneous Coronary Intervention
  • Humans
  • Hematologic Agents
  • General & Internal Medicine
  • Fibrinolytic Agents
  • Drug Therapy, Combination
  • Coronary Artery Disease